Mercado global de células estaminais alogénicas – Tendências do setor e previsão para 2028

Análise e insights de mercado: Mercado global de células estaminais alogénicas

Espera-se que o mercado de células estaminais alogénicas testemunhe um crescimento do mercado a uma taxa de 12,04% no período de previsão de 2021 a 2028 e deverá atingir os 1.534,18 milhões de dólares até 2028. O relatório Data Bridge Market Research sobre o mercado das células estaminais alogénicas fornece análises e insights em relação aos vários fatores que deverão prevalecer ao longo do período de previsão, ao mesmo tempo que fornecem os seus impactos no crescimento do mercado. O aumento dos avanços tecnológicos está a aumentar o crescimento do mercado de células estaminais alogénicas.

As células estaminais podem ser definidas como células que possuem capacidades de autorrenovação e clonogénicas. Estas células podem diferenciar-se em múltiplas linhagens celulares. A totipotência e a auto-renovação são características das células estaminais. A terapia alogénica com células estaminais utiliza células de um dador. No tipo mais comum de transplante alogénico, as células estaminais são obtidas de um dador cujo tipo de tecido corresponde diretamente ao do doente.

Os principais fatores que deverão impulsionar o crescimento do mercado das células estaminais alogénicas no período de previsão são o aumento dos requisitos não cumpridos nas doenças crónicas e o aumento dos gastos com a investigação com células estaminais. Além disso, o aumento da incidência de doenças crónicas, como o cancro e as doenças cardiovasculares, está a impulsionar ainda mais o crescimento do mercado das células estaminais alogénicas. Por outro lado, prevê-se que a dificuldade relacionada com as orientações governamentais pouco claras para o desenvolvimento de produtos impeça ainda mais o crescimento do mercado de células estaminais alogénicas no período de tempo.

Além disso, o aumento do investimento das empresas farmacêuticas e biofarmacêuticas na investigação sobre células estaminais proporcionará ainda mais oportunidades para o crescimento do mercado das células estaminais alogénicas nos próximos anos. No entanto, as restrições técnicas associadas ao aumento da produção poderão criar ainda mais desafios para o crescimento do mercado das células estaminais alogénicas num futuro próximo.

This allogeneic stem cells market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the allogeneic stem cells market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Allogeneic Stem Cells Market Scope and Market Size

The allogeneic stem cells market is segmented on the basis of product type, application and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

• On the basis of product type, the allogeneic stem cells market is segmented into close family member transplant, MUD (matched unrelated donor) transplant.
• On the basis of application, the allogeneic stem cells market is segmented into regenerative therapy, drug discovery and development.
• On the basis of end users, the allogeneic stem cells market is segmented into therapeutics companies, cell and tissue banks, tools and reagents companies, service companies

Allogeneic Stem Cells Market Country Level Analysis

The allogeneic stem cells market is analysed and market size insights and trends are provided by country, product type, application and end user as referenced above.      

The countries covered in the allogeneic stem cells market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the allogeneic stem cells market due to the rise in the investment scenario. Furthermore, the increase in the economic growth and the upsurge in the prevalence of target chronic diseases will further boost the growth of the allogeneic stem cells market in the region during the forecast period. Asia Pacific is projected to observe significant amount of growth in the allogeneic stem cells market due to the rise in the development of stem cell-based therapies. Moreover, the initiatives taken by the government for advancing regenerative medicines is further anticipated to propel the growth of the allogeneic stem cells market in the region in the coming years.

The country section of the allogeneic stem cells market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The allogeneic stem cells market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for allogeneic stem cells market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the allogeneic stem cells market. The data is available for historic period 2010-2019.

Competitive Landscape and Allogeneic Stem Cells Market Share Analysis

The allogeneic stem cells market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to allogeneic stem cells market.

Os principais players abrangidos no relatório de mercado de células estaminais alogénicas são a Osiris Therapeutics, Inc., MEDIPOST Co., Ltd., Cynata Therapeutics, Bio Solution Co Ltd, STEMCELL Technologies Inc., Astellas Pharma Inc., Cellular Engineering Technologies Inc. , Takeda Pharmaceutical Company Limited., TAKARA BIO INC., US Stem Cell, Inc., BrainStorm Cell Therapeutics Inc., STEMPEUTICS RESEARCH PVT LTD, Athersys., JCR Pharmaceuticals Co., Ltd., MiMedx., Lineage Cell Therapeutics, Inc. , Thermo Fisher Scientific, Vericel Corporation., AbbVie Inc., Mesoblast Ltd., entre outros players nacionais e globais. Os dados de quota de mercado estão disponíveis para a global, América do Norte, Europa, Ásia-Pacífico (APAC), Médio Oriente e África (MEA) e América do Sul separadamente. Os analistas DBMR compreendem os pontos fortes competitivos e fornecem análises competitivas para cada concorrente em separado.

SKU-62897